
Biogen Idec has announced the findings from a randomized, multicenter, dose-blinded clinical trial that evaluated the effect of Avonex®(interferon beta-1a) dose titration, or gradual dose escalation, on flu-like symptoms associated with the therapy.
The data demonstrated that dose titration with Avonex over three weeks at the initiation of treatment resulted in a 76 percent reduction in flu-like symptom severity between pre-injection and the four-six-hour post-injection time point versus no titration (p<0.001).... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1765